| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.34B | +7.2% |
| Cost of Revenue | $3.57B | +3.9% |
| Gross Profit | $1.77B | +14.5% |
| R&D Expense | $93.6M | -0.4% |
| SG&A Expense | $730.6M | +3.6% |
| Operating Income | $1.03B | +31.0% |
| Interest Expense | $38.7M | -25.1% |
| Pre-tax Income | $993.8M | +34.8% |
| Income Tax | $186.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $415.1M | +583.9% |
| Short-term Investments | $7.2M | -14.3% |
| Accounts Receivable | $661.1M | +11.2% |
| Inventory | $704.8M | +0.8% |
| Current Assets | $1.88B | +31.4% |
| Total Assets | $3.47B | +24.1% |
| Current Liabilities | $1.31B | +29.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $945.7M | +28.5% |
| Capital Expenditures | $163.6M | -34.6% |
| Investing Cash Flow | -$174.4M | +45.4% |
| Financing Cash Flow | -$418.6M | -3.1% |
| Free Cash Flow | $782.1M | +60.9% |
| +26.8% |
| Net Income | $806.9M | +36.7% |
| EPS (Basic) | $22.67 | +36.5% |
| EPS (Diluted) | $22.54 | +36.3% |
| Long-term Debt |
| $833.1M |
| -27.1% |
| Total Liabilities | $2.62B | +4.3% |
| Stockholders' Equity | $850.2M | +198.0% |